The company said Jennifer M. Kirk, its Global Controller and Principal Accounting Officer, notified it of her decision to resign effective May 2, 2025. The company said she is leaving to become chief executive officer of Exubrion Therapeutics, a privately held company, and that her resignation was notified on March 12, 2025.

1. 01

   The company said Jennifer M. Kirk, its Global Controller and Principal Accounting Officer, notified it of her decision to resign effective May 2, 2025. The company said she is leaving to become chief executive officer of Exubrion Therapeutics, a privately held company, and that her resignation was notified on March 12, 2025.

2. 02

   Medtronic said Kirk's resignation did not result from any disagreement relating to the company's operations, policies or practices. It said Kirk will remain at the company through May 2, 2025 to support a smooth transition.

3. 03

   The company said it has appointed Denise L. Blomquist, currently its Assistant Global Controller, as Global Controller and Principal Accounting Officer, effective March 17, 2025. It said Blomquist has worked at the company since 2004 and has 21 years of tenure, and that she received a bachelor's degree in accounting from the University of Wisconsin - Madison.

4. 04

   The company said Blomquist will receive a base salary commensurate with other similarly situated persons at the company and will participate in the Medtronic Incentive Plan and the 2021 Long-Term Incentive Plan at similar levels. It said her employment is at-will. The company also said there are no family relationships between Blomquist and any director or executive officer that require disclosure, and no related-person transactions requiring disclosure under Item 404(a).

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.